Uro Gen Pharma Ltd reported raising $120 Million in an initial SEC Form D filing, from an offering of $120 Million
Round Type
Venture
Quick answer
UroGen Pharma raised $120 Million in a funding round, dated July 26, 2023. UroGen Pharma is based in Princeton, New Jersey, United States.
- How much did UroGen Pharma raise?
- UroGen Pharma raised $120 Million in a funding round on July 26, 2023.
- What does UroGen Pharma do?
- UroGen Pharma is a biotech company that builds novel solutions to revolutionize the way specialty cancers and urologic diseases are treated – because patients deserve better options.
- Where is UroGen Pharma based and how big is it?
- UroGen Pharma is based in Princeton, New Jersey, United States. Fundz records about 300 employees.
- Who are the decision-makers at UroGen Pharma?
- Fundz holds 4 contacts at UroGen Pharma, including the CFO. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Biotechnology around the same time
Companies in the same sectors as UroGen Pharma that raised within 45 days of this round, from Fundz verified event records.
- Cellectar raised $25M on September 8, 2023.
- HeartSciences raised $1M (Seed) on September 7, 2023.
- Arthrosi Therapeutics raised $7M on September 5, 2023.
- Cellectar raised $103M (Post-IPO Equity) on September 5, 2023.
- Cardio Flow, Inc. raised $100K (Seed) on September 1, 2023.
- Beta Bionics raised $99M on August 28, 2023.
Who to call at UroGen Pharma, and when
A new round usually means UroGen Pharma is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day UroGen Pharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at UroGen Pharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at UroGen Pharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment UroGen Pharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
UroGen Pharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.